Under the patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, His Excellency Sheikh Khalifa bin Tahnoon bin Mohammed Al Nahyan attends the Grand Finale of the 33rd UAE President Cup for Arabian Purebred Horses at Abu Dhabi Turf Club
ABU DHABI, UAE, Dec. 18, 2025 /PRNewswire/ -- Under the patronage of…
The Backbone of the National Games: Driving Success in Hong Kong and Macao with ‘GAC Strength’
HONG KONG and MACAO, Dec. 18, 2025 /PRNewswire/ -- On December 15,…
Exicom launches an integrated EV charging rollout solution to help CPOs and EV manufacturers scale their charging networks
NEW DELHI, Dec. 18, 2025 /PRNewswire/ -- Exicom Tele-Systems Limited (BSE: 544133)…
Nissan Selects IPfolio from Clarivate
Managing IP with advanced workflow automation technology and leading dataLONDON, Dec. 18,…
Singapore Airshow 2026 Marks 10th Edition with New Frontiers in Aviation and Space
SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- Singapore Airshow, one of the most influential international aerospace and defence exhibition,…
UN Global Compact Showcases AI, Innovation, and Global Collaboration in Fighting Corruption at COSP11 Private Sector Forum
DOHA, Qatar, Dec. 16, 2025 /PRNewswire/ -- The United Nations Global Compact,…
Databricks Grows >55% YoY, Surpasses $4.8B Revenue Run-Rate, and is Raising >$4B Series L at $134B Valuation
Company accelerates investments in Agent Bricks, Lakebase and Databricks Apps to power…
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted…
InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 17, 2025 20:48 ET | Source: InnoCare Pharma BEIJING, Dec. 17,…
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sapu BioScience today…
